Login

Journal Front Page

News & Events

  • Call for article for July 2025 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 June, 2025 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • April 2025 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 14, Issue 2 (April 2025 Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

PHYTOCHEMICAL AND PHARMACOLOGICAL EVALUATION OF ANTIHYPERLIPIDIMIC ACTIVITY OF RAPHANUS SATIVUS LINN ON RATS

Jyoti Kumari*, Saeffi Thomas, Virendra Kumar Sharma, A. K. Singhai

School of Pharmacy, LNCT University, Bhopal (M.P.)

ABSTRACT

This study aimed to evaluate the phytochemical composition and pharmacological activity of Raphanus sativus Linn (radish) in relation to its anti-hyperlipidemic effects in rats. The phytochemical analysis of the plant extract revealed the presence of various bioactive compounds such as flavonoids, phenolic compounds, and alkaloids. In the pharmacological evaluation, hyperlipidemia was induced in rats using a high-fat diet, and the effects of Raphanus sativus extract on lipid profile parameters, including total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), were assessed. The study found that treatment with Raphanus sativus extract significantly reduced the levels of total cholesterol, triglycerides, and LDL-C, while increasing the levels of HDL-C in hyperlipidemic rats. These findings suggest that Raphanus sativus may possess potent anti-hyperlipidemic activity and could be a potential therapeutic agent for managing hyperlipidemia and related disorders.

Keywords: Raphanus sativus, hyperlipidemia, anti-hyperlipidemic activity, lipid profile, phytochemical analysis, rats.


[Full Text Article]